Management of Hypertension, Obesity, Lipids, and Diabetes with Glucagon-like Peptide 1 Receptor Agonists

Hyperglycemia is considered one of the main risk factors for the development of cardiovascular diseases, and the situation becomes worse if the condition is associated with uncontrolled hypertension, dyslipidemia, and overweight or obesity. Since the first glucagon-like peptide 1 receptor agonist (G...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hridish Narayan Chakravarti, Jothydev Kesavadev, Rajiv Kovil, Debmalya Sanyal, Sambit Das, Nirmalya Roy, Dilip Kumar, Binayak Deb, Soumyabrata Roy Chaudhuri, Pankaj Aneja
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer Medknow Publications 2024-01-01
Serija:	International Journal of Diabetes and Technology
Teme:	atherosclerotic cardiovascular disease glucagon-like peptide receptor agonists hypertension oral semaglutide type 2 diabetes
Online dostop:	https://journals.lww.com/10.4103/ijdt.ijdt_11_24
Oznake:	Označite Brez oznak, prvi označite!